The available evidence on demineralised bone matrix in trauma and orthopaedic surgery: a systematic review

J. van der Stok, K.A. Hartholt, D.A.L. Schoenmakers, J.J.C. Arts

Onderzoeksoutput: Bijdrage aan tijdschriftArtikel recenserenAcademicpeer review

4 Citaties (Scopus)

Uittreksel

Objectives: The aim of this systematic literature review was to assess the clinical level of evidence of commercially available demineralised bone matrix (DBM) products for their use in trauma and orthopaedic related surgery. Methods: A total of 17 DBM products were used as search terms in two available databases: Embase and PubMed according to the Preferred Reporting Items for Systematic Reviews and Meta Analyses statement. All articles that reported the clinical use of a DBM-product in trauma and orthopaedic related surgery were included. Results: The literature search resulted in 823 manuscripts of which 64 manuscripts met the final inclusion criteria. The included manuscripts consisted of four randomised controlled trials (level I), eight cohort studies (level III) and 49 case-series (level IV). No clinical studies were found for ten DBM products, and most DBM products were only used in combination with other grafting materials. DBM products were most extensively investigated in spinal surgery, showing limited level I evidence that supports the use Grafton DBM (Osteotech, Eatontown, New Jersey) as a bone graft extender in posterolateral lumbar fusion surgery. DBM products are not thoroughly investigated in trauma surgery, showing mainly level IV evidence that supports the use of Allomatrix (Wright Medical, London, United Kingdom), DBX (DePuy Synthes, Zuchwil, Switzerland), Grafton DBM, or OrthoBlast (Citagenix Laval, Canada) as bone graft extenders. Conclusions: The clinical level of evidence that supports the use of DBM in trauma and orthopaedic surgery is limited and consists mainly of poor quality and retrospective case-series. More prospective, randomised controlled trials are needed to understand the clinical effect and impact of DBM in trauma and orthopaedic surgery.

TaalEngels
Pagina's423-432
Aantal pagina's10
TijdschriftBone and Joint Research
Volume6
Nummer van het tijdschrift7
DOI's
StatusGepubliceerd - 1 jul 2017

Vingerafdruk

Bone Matrix
Orthopedics
Wounds and Injuries
Manuscripts
Randomized Controlled Trials
Transplants
Bone and Bones
Switzerland
PubMed
Canada
Meta-Analysis
Cohort Studies
Databases

Trefwoorden

    Citeer dit

    van der Stok, J. ; Hartholt, K.A. ; Schoenmakers, D.A.L. ; Arts, J.J.C./ The available evidence on demineralised bone matrix in trauma and orthopaedic surgery : a systematic review. In: Bone and Joint Research. 2017 ; Vol. 6, Nr. 7. blz. 423-432
    @article{0b7be625c6bc4e3ba0ef54c0cd7a1ead,
    title = "The available evidence on demineralised bone matrix in trauma and orthopaedic surgery: a systematic review",
    abstract = "Objectives: The aim of this systematic literature review was to assess the clinical level of evidence of commercially available demineralised bone matrix (DBM) products for their use in trauma and orthopaedic related surgery. Methods: A total of 17 DBM products were used as search terms in two available databases: Embase and PubMed according to the Preferred Reporting Items for Systematic Reviews and Meta Analyses statement. All articles that reported the clinical use of a DBM-product in trauma and orthopaedic related surgery were included. Results: The literature search resulted in 823 manuscripts of which 64 manuscripts met the final inclusion criteria. The included manuscripts consisted of four randomised controlled trials (level I), eight cohort studies (level III) and 49 case-series (level IV). No clinical studies were found for ten DBM products, and most DBM products were only used in combination with other grafting materials. DBM products were most extensively investigated in spinal surgery, showing limited level I evidence that supports the use Grafton DBM (Osteotech, Eatontown, New Jersey) as a bone graft extender in posterolateral lumbar fusion surgery. DBM products are not thoroughly investigated in trauma surgery, showing mainly level IV evidence that supports the use of Allomatrix (Wright Medical, London, United Kingdom), DBX (DePuy Synthes, Zuchwil, Switzerland), Grafton DBM, or OrthoBlast (Citagenix Laval, Canada) as bone graft extenders. Conclusions: The clinical level of evidence that supports the use of DBM in trauma and orthopaedic surgery is limited and consists mainly of poor quality and retrospective case-series. More prospective, randomised controlled trials are needed to understand the clinical effect and impact of DBM in trauma and orthopaedic surgery.",
    keywords = "Bone defects, Bone grafts, Demineralised bone matrix",
    author = "{van der Stok}, J. and K.A. Hartholt and D.A.L. Schoenmakers and J.J.C. Arts",
    year = "2017",
    month = "7",
    day = "1",
    doi = "10.1302/2046-3758.67.BJR-2017-0027.R1",
    language = "English",
    volume = "6",
    pages = "423--432",
    journal = "Bone and Joint Research",
    issn = "2046-3758",
    publisher = "British Editorial Society of Bone and Joint Surgery",
    number = "7",

    }

    The available evidence on demineralised bone matrix in trauma and orthopaedic surgery : a systematic review. / van der Stok, J.; Hartholt, K.A.; Schoenmakers, D.A.L.; Arts, J.J.C.

    In: Bone and Joint Research, Vol. 6, Nr. 7, 01.07.2017, blz. 423-432.

    Onderzoeksoutput: Bijdrage aan tijdschriftArtikel recenserenAcademicpeer review

    TY - JOUR

    T1 - The available evidence on demineralised bone matrix in trauma and orthopaedic surgery

    T2 - Bone and Joint Research

    AU - van der Stok,J.

    AU - Hartholt,K.A.

    AU - Schoenmakers,D.A.L.

    AU - Arts,J.J.C.

    PY - 2017/7/1

    Y1 - 2017/7/1

    N2 - Objectives: The aim of this systematic literature review was to assess the clinical level of evidence of commercially available demineralised bone matrix (DBM) products for their use in trauma and orthopaedic related surgery. Methods: A total of 17 DBM products were used as search terms in two available databases: Embase and PubMed according to the Preferred Reporting Items for Systematic Reviews and Meta Analyses statement. All articles that reported the clinical use of a DBM-product in trauma and orthopaedic related surgery were included. Results: The literature search resulted in 823 manuscripts of which 64 manuscripts met the final inclusion criteria. The included manuscripts consisted of four randomised controlled trials (level I), eight cohort studies (level III) and 49 case-series (level IV). No clinical studies were found for ten DBM products, and most DBM products were only used in combination with other grafting materials. DBM products were most extensively investigated in spinal surgery, showing limited level I evidence that supports the use Grafton DBM (Osteotech, Eatontown, New Jersey) as a bone graft extender in posterolateral lumbar fusion surgery. DBM products are not thoroughly investigated in trauma surgery, showing mainly level IV evidence that supports the use of Allomatrix (Wright Medical, London, United Kingdom), DBX (DePuy Synthes, Zuchwil, Switzerland), Grafton DBM, or OrthoBlast (Citagenix Laval, Canada) as bone graft extenders. Conclusions: The clinical level of evidence that supports the use of DBM in trauma and orthopaedic surgery is limited and consists mainly of poor quality and retrospective case-series. More prospective, randomised controlled trials are needed to understand the clinical effect and impact of DBM in trauma and orthopaedic surgery.

    AB - Objectives: The aim of this systematic literature review was to assess the clinical level of evidence of commercially available demineralised bone matrix (DBM) products for their use in trauma and orthopaedic related surgery. Methods: A total of 17 DBM products were used as search terms in two available databases: Embase and PubMed according to the Preferred Reporting Items for Systematic Reviews and Meta Analyses statement. All articles that reported the clinical use of a DBM-product in trauma and orthopaedic related surgery were included. Results: The literature search resulted in 823 manuscripts of which 64 manuscripts met the final inclusion criteria. The included manuscripts consisted of four randomised controlled trials (level I), eight cohort studies (level III) and 49 case-series (level IV). No clinical studies were found for ten DBM products, and most DBM products were only used in combination with other grafting materials. DBM products were most extensively investigated in spinal surgery, showing limited level I evidence that supports the use Grafton DBM (Osteotech, Eatontown, New Jersey) as a bone graft extender in posterolateral lumbar fusion surgery. DBM products are not thoroughly investigated in trauma surgery, showing mainly level IV evidence that supports the use of Allomatrix (Wright Medical, London, United Kingdom), DBX (DePuy Synthes, Zuchwil, Switzerland), Grafton DBM, or OrthoBlast (Citagenix Laval, Canada) as bone graft extenders. Conclusions: The clinical level of evidence that supports the use of DBM in trauma and orthopaedic surgery is limited and consists mainly of poor quality and retrospective case-series. More prospective, randomised controlled trials are needed to understand the clinical effect and impact of DBM in trauma and orthopaedic surgery.

    KW - Bone defects

    KW - Bone grafts

    KW - Demineralised bone matrix

    UR - http://www.scopus.com/inward/record.url?scp=85026242350&partnerID=8YFLogxK

    U2 - 10.1302/2046-3758.67.BJR-2017-0027.R1

    DO - 10.1302/2046-3758.67.BJR-2017-0027.R1

    M3 - Review article

    VL - 6

    SP - 423

    EP - 432

    JO - Bone and Joint Research

    JF - Bone and Joint Research

    SN - 2046-3758

    IS - 7

    ER -